Cargando…
Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19
BACKGROUND AND AIM: The aim of this study is to evaluate whether the long-term (≥4 weeks) use of proton pump inhibitors (PPIs) is a risk factor for intubation requirement and mortality in patients hospitalized for COVID-19. MATERIALS AND METHODS: In this multicentric retrospective study, a total of...
Autores principales: | YOZGAT, Ahmet, KASAPOĞLU, Benan, CAN, Güray, TANOĞLU, Alpaslan, SAKİN, Yusuf Serdar, YALÇIN, Kadir Serkan, GÜRLER, Müjgan, KAPLAN, Mustafa, KABAN, Mehmet Göktürk, KIRSOY, Mehmet, KARA, Umut, KEKİLLİ, Murat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569806/ https://www.ncbi.nlm.nih.gov/pubmed/34110723 http://dx.doi.org/10.3906/sag-2103-80 |
Ejemplares similares
-
Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015) -
Inefficacy of Triple Therapy and Comparison of Two Different Bismuth-containing Quadruple Regimens as a Firstline Treatment Option for Helicobacter pylori
por: Kekilli, Murat, et al.
Publicado: (2016) -
New diagnostic approach to diagnosis of achalasia after recent Chicago classification
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015) -
Boceprevir-induced Herpes Zoster
por: Babalı, Ayşegul, et al.
Publicado: (2018) -
Role of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver disease
por: Kasapoglu, Benan, et al.
Publicado: (2016)